Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies
Curtis BR, Hsu YS, Podoltsev N, Lacy J, Curtis S, Samuel MS, Zutavern K, DeSimone RA, Bougie DW, Aster RH. Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies. Blood 2018, 131: 1486-1489. PMID: 29439950, PMCID: PMC5877442, DOI: 10.1182/blood-2017-10-812461.Peer-Reviewed Original ResearchMeSH KeywordsAgedAutoantibodiesColonic NeoplasmsFemaleHumansMaleMiddle AgedOxaliplatinPurpura, Thrombocytopenic, IdiopathicStomach Neoplasms